skip to main content

H.R. 3250 (114th): DXM Abuse Prevention Act of 2015

Call or Write Congress

To amend the Federal Food, Drug, and Cosmetic Act to prevent the abuse of dextromethorphan, and for other purposes.

The bill’s titles are written by its sponsor.

Sponsor and status

Bill Johnson

Sponsor. Representative for Ohio's 6th congressional district. Republican.

Read Text »
Last Updated: Jul 8, 2016
Length: 12 pages
Jul 28, 2015
114th Congress (2015–2017)
Died in a previous Congress

This bill was introduced on April 27, 2016, in a previous session of Congress, but it did not receive a vote.

Although this bill was not enacted, its provisions could have become law by being included in another bill. It is common for legislative text to be introduced concurrently in multiple bills (called companion bills), re-introduced in subsequent sessions of Congress in new bills, or added to larger bills (sometimes called omnibus bills).


20 Cosponsors (10 Republicans, 10 Democrats)


Position statements

What legislators are saying

Energy & Commerce Health Subcommittee Advances Matsui-Johnson DXM Abuse Prevention Act
    — Rep. Doris Matsui [D-CA6] (Co-sponsor) on Apr 20, 2016

Welchs Bipartisan Opioid Amendment Clears Committee Hurdle, Heads to House Floor for Vote
    — Rep. Peter Welch [D-VT0] on Apr 27, 2016

#SubHealth to Vote on Package to Address Opioid and Drug Abuse Epidemic
    — Rep. Susan Brooks [R-IN5, 2013-2020] on Apr 18, 2016

More statements at ProPublica Represent...


Jul 28, 2015

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Apr 20, 2016
Considered by Health

A committee held a hearing or business meeting about the bill.

Apr 26, 2016
Considered by House Committee on Energy and Commerce

A committee held a hearing or business meeting about the bill.

Apr 27, 2016
Ordered Reported

A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

Jul 8, 2016
Reported by House Committee on Energy and Commerce

A committee issued a report on the bill, which often provides helpful explanatory background on the issue addressed by the bill and the bill's intentions.

H.R. 3250 (114th) was a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Bills numbers restart every two years. That means there are other bills with the number H.R. 3250. This is the one from the 114th Congress.

This bill was introduced in the 114th Congress, which met from Jan 6, 2015 to Jan 3, 2017. Legislation not passed by the end of a Congress is cleared from the books.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 3250 — 114th Congress: DXM Abuse Prevention Act of 2015.” 2015. September 28, 2021 <>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from, the official portal of the United States Congress. is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.